Outcome of the Rights Issue Committee held 09th September,2026.

IBL Indrayani Biotech Inclusive Growth 09-09-2026 Listing Operations Department, BSE Limited, PJ. Towers, Dalal Street, Mumbai - 400 001. Scrip ID: 526445 Sub: Outcome of the Rights Issue Committee ("Committee”) Meeting held on September 09,2026 Dear Sir/Madam, This is to inform the Eligible Equity Shareholders of the Company that the schedule of the partly paid-up Rights Issue has been revised by the Rights Issue Committee at its meeting held on September 09, 2026. The Rights Issue schedule, which was initially scheduled to open on Wednesday, May 27, 2026 and close on Thursday, June 25, 2026, was subsequently extended from Thursday, June 25, 2026 to Friday, July 24, 2026 and was further postponed until further notice. The Rights issue Committee, in its meeting held on September 09, 2026, has decided to revise the Schedule of the rights issue. Accordingly, the Rights issue will now remain open from September 15, 2026 to October 14, 2026. Further; the last date for on-market renunciation has also been revised to October 08, 2026. The revised Letter of Offer (LOF) is uploaded on the www.bseindia.com. And revised Letter of Offer (LOF), Abridged Letter of Offer (ALOF), Composite Application Form (CAF), Entitlement Letter and other related issue documents shall be made available on the website of the Company atwww.indrayani.com. You are requested to take the above information on record and acknowledge the same. Thanking you, Yours faithfully, For Indrayani Biotech Limited Swaminathan Govindarajan Whole time Director DIN: 02481041 Block 1, 33, SIDCO Electronic Complex, Thiru Vi Ka Industrial Estate, Guindy, Chennai 600032 Ph: +91-44-2/ 4+491-6443-27255021146 | www.indrayani.com | info@indrayani.com | CIN: L40100TN1992PLC129301